Biological and reagent material - GEM-x flex gene expression and sample prep/dual index kits
Ended Awarded Last action
- Contract number
- 75N95D25F40021
- Awardee
-
10X Genomics, Inc. UEI D1NLDEZ14TV5
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $247,506
Award facts
- Contract value 100% obligated
- $247,506.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Pleasanton, CA 94588, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $247,506 |
About this award
The National Institute on Aging awarded a $247,506 firm fixed-price delivery order to 10X Genomics, Inc. on August 1, 2025, for GEM-X Flex Gene Expression and Sample Prep/Dual Index Kits and GEM-X Flex Gene Expression Human N-Plex consumables for 64 samples. The contract is set to be completed by October 31, 2025, with performance taking place at 10X Genomics' facility in Pleasanton, California. This delivery order was issued without a set-aside designation and represents part of 10X Genomics' larger indefinite delivery contract vehicle with the National Institute on Aging, which is valued at up to $7 million through July 2029.
10X Genomics is a leading biotechnology company specializing in advanced genomic analysis platforms and reagents for single-cell and spatial transcriptomics research. The company has established itself as a critical supplier to the National Institutes of Health and its component institutes, including the National Institute on Aging, providing sophisticated genomic analysis products that support biomedical research into age-related conditions, neurological disorders, and other disease areas. Under the broader indefinite delivery contract, 10X Genomics has delivered a range of specialized products including cell partitioning machines, Chromium controllers and consumables, and various sequencing kits. This particular delivery order for gene expression kits and sample preparation materials continues that support, enabling the agency's research capabilities in molecular analysis and aging-related biomedical research.
Quick answers
Who was awarded contract 75N95D25F40021?
75N95D25F40021 was awarded to 10X Genomics, Inc. by National Institute on Aging (National Institutes of Health) on August 1, 2025.
How much is contract 75N95D25F40021 worth?
The government has obligated $247,506 on 75N95D25F40021.
Is contract 75N95D25F40021 an order under another contract?
Yes. 75N95D25F40021 is a delivery order under 75N95024D00029, an indefinite delivery contract.
Was contract 75N95D25F40021 competed?
The extent of competition for 75N95D25F40021 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award